rethinkPeptides Search
Menu
Research citation

The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy.

Scientific reports, 14(1), 24433

Citation

Kornelius, Edy; Huang, Jing-Yang; Lo, Shih-Chang; Huang, Chien-Ning; Yang, Yi-Sun. (2024). The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy.. Scientific reports, 14(1), 24433. https://doi.org/10.1038/s41598-024-75965-2